Citation Impact
Citing Papers
Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.
1992
Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD
2004
Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence
2003
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation
1996
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
A Pugh score of 8 adequately selects patients with parenchymal cirrhosis for liver transplantation
1992
Long‐term prognosis and prognostic factors of liver cirrhosis in the 1980s
1994
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Survival and prognostic indicators in compensated and decompensated cirrhosis
1986
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
2003 Standout
Hepatocellular carcinoma
2018 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
1992
Dynamics of fat cell turnover in humans
2008 StandoutNature
Prognostic significance of portal hemodynamics in patients with compensated cirrhosis
1993
Predictive value of serum procollagen-III-peptide for the survival of patients with cirrhosis
1991
MELDvsChild-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis
2005
The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death
1996
Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis
2005
1-Year Survey of Patients with Advanced Liver Cirrhosis: Prognostic Value of Clinical and Laboratory Indexes Identified by the Cox Regression Model
1992
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa
1989
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
1988
Follow‐up study of 582 liver cirrhosis patients for 26 years in Japan
1987
Prediction of the prognosis of liver cirrhosis in Japanese using cox’s proportional hazard model
1987
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma
2004
The metabolic syndrome
2010 Standout
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
1996
Nonalcoholic Fatty Liver Disease
2002 Standout
Nonalcoholic steatohepatitis: A study of 49 patients
1989
Prognostic Index of Cirrhotic Patients with Hepatic Encephalopathy with and Without Hepatocellular Carcinoma
2004
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
2002 Standout
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance
2002
Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis
1991
Prognostic Usefulness of Ultrasonographic Signs of Portal Hypertension in Patients With Child–Pugh Stage A Liver Cirrhosis
1999
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study
1994
Prognostic significance of diabetes in patients with cirrhosis*1
1994
Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis
2004
MyoD or Myf-5 is required for the formation of skeletal muscle
1993 Standout
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Prognostic indicators in alcoholic cirrhotic men
1988
Evaluation of Splanchnic Angiography as a Prognostic Index of Survival in Patients with Cirrhosis
1991
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis
2003
AGA technical review on nonalcoholic fatty liver disease
2002
Hepatic effects of dietary weight loss in morbidly obese subjects
1991
Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis
2002
Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy
2004
Prognostic significance of hepatic encephalopathy in patients with cirrhosis
1999
The metabolic syndrome
2005 Standout
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
2001
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
MELD and PELD: Application of survival models to liver allocation
2001
HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN
1989 StandoutNobel
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Long term prognosis of fatty liver: risk of chronic liver disease and death
2004
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
Superiority of the Child-Pugh Classification to Quantitative Liver Function Tests for Assessing Prognosis of Liver Cirrhosis
1989
Optimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices
1994
Prognostic evaluation of patients with parenchymal cirrhosis
1997
Gastrointestinal Hormone Responses to Meals Before and After Gastric Bypass and Vertical Banded Gastroplasty
1990
Genetic factors for resistance to diet-induced obesity and associated metabolic traits on mouse chromosome 17
2009
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
2008
A prognostic model for predicting survival in cirrhosis with ascites
2001
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B
1995
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
1990 Standout
Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis
1988
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites
1988
Clinicopathologic Course of Hepatitis B Infection in Surface Antigen Carriers Following Living-Related Renal Transplantation
1994
What We Talk About When We Talk About Fat
2014 Standout
Chronic non‐A, non‐B hepatitis developed after transfusions, illicit self‐injections or sporadically. Outcome during long‐term follow‐up – a comparison
1989
Prognostic value of peritoneoscopic findings in cirrhosis of the liver
1990
Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study
1989
Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices
1992
Non-alcoholic fatty liver: another feature of the metabolicsyndrome?
1999
Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis
1992 StandoutNobel
Long‐term prognosis of patients with alcoholic liver cirrhosis: a 15‐year follow‐up study of 100 Norwegian patients admitted to one unit
2004
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Hepatocellular Carcinoma
2011 Standout
Diagnosis of fatty liver disease
2003
Liver Biopsy
2001 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Infection in Organ-Transplant Recipients
1998 Standout
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
2003 Standout
Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding
1994
Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation
1995
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Factors influencing survival at one year in patients with nonbiliary hepatic parenchymal cirrhosis
1990
Adjuvant Therapy of Colorectal Cancer
1988
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Hepatocellular Carcinoma
2019 Standout
Monoethylglicinexylidide test: A prognostic indicator of survival in cirrhosis
1994
CHRONIC LIVER DISEASE DEVELOPING AFTER OUTBREAK OF HBsAg-NEGATIVE HEPATITIS IN HÆMODIALYSIS UNIT
1975
The Existence of Publication Bias and Risk Factors for Its Occurrence
1990 Standout
The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis
1986
Predictors of one-year pretransplant survival in patients with cirrhosis
1991
Primary Biliary Cirrhosis
1987 Standout
Occurrence of hepatitis A, B, and non-A/non-B in the United States
1984
An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis
1989 StandoutScienceNobel
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
1985
Prognostic value of the aminopyrine breath test in cirrhotic patients
1986
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
1983
Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation
1986
Steroid treatment of alcoholic hepatitis
1978
Prognostic score in liver cirrhosis developed using the cox’s proportional hazard regression model
1987
Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis
2000
e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen.
1975
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
1978 Standout
Prediction of Variceal Hemorrhage in Cirrhosis: A Prospective Follow-up Study
1991
Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics
1987
Viruses in Human Cancers
1991 StandoutScienceNobel
Improvement of prognostic power of the Child–Pugh classification of liver cirrhosis by hyaluronan
2003
Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation
2002
Does malnutrition affect survival in cirrhosis?
1996
Prognostic Significance of Serum Bile Acids in Cirrhosis
1986
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation
2004
A case/control study of the association between primary liver cancer and hepatitis b infection in senegal
1975
Liver cell models in in vitro toxicology.
1998
Serologic Markers of Hepatitis B Virus Infection
1986
Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients*1
1995
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
1997 Standout
Clinical, Epidemiological and Prognostic Aspects of Hepatitis “Non-A, Non-B”—a Comparison with Hepatitis A and B
1979
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
1990 StandoutNobel
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Compensated cirrhosis: Natural history and prognostic factors
1987
A framework for evaluating and conducting prognostic studies: An application to cirrhosis of the liver
1989
Development of Chronic Liver Disease after Acute Non-A, Non-B Post-Transfusion Hepatitis
1977
Body composition and adipose tissue cellularity before and after jejuno‐ileostomy in severely obese subjects
1977
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.
1995 StandoutNobel
Repeated assessment of risk factors in survival analysis
1992
Transvenous Liver Biopsy
1982
Complexity and contradiction in clinical trial research
1987
Plasma calprotectin: A new prognostic marker of survival in alcohol-induced cirrhosis
1995
A Pugh score of 8 adequately selects patients with parenchymal cirrhosis for liver transplantation
1992
Meta-analysis in clinical trials
1986 Standout
Works of E Juhl being referenced
Differential diagnosis of jaundice a statistical algorithm
1983
Morphological Changes in Liver Biopsies from Patients with Rheumatoid Arthritis
1976
Acute Viral Hepatitis: A Comparative Study of Clinical, Biochemical, Morphological and Immunological Features in Patients with and without Australia Antigen
1975
Prognosis after the First Episode of Gastrointestinal Bleeding or Coma in Cirrhosis: Survival and Prognostic Factors
1989
Alcoholic Hepatitis Superimposed on Cirrhosis. Clinical Significance and Effect of Long-term Prednisone Treatment
1976
Fatal outcome after jejunoileal bypass for obesity
1981
Clinical relevance of restrictive morphological criteria for the diagnosis of cirrhosis in liver biopsies
1981
Updating Prognosis and Therapeutic Effect Evaluation in Cirrhosis with Cox's Multiple Regression Model for Time-Dependent Variables
1986
Main Causes of Death in Cirrhosis
1983
Aspects of the Natural History of Gastrointestinal Bleeding in Cirrhosis and the Effect of Prednisone
1981
Incidence and Meaning of Persistence of Australia Antigen in Patients with Acute Viral Hepatitis: Development of Chronic Hepatitis
1971
A Therapeutic Index That Predicts the Individual Effects of Prednisone in Patients With Cirrhosis
1985
The prognostic value of clinical and laboratory data in patients with cirrhosis.
1970
Liver Histology in a ‘Normal’ Population—Examinations of 503 Consecutive Fatal Traffic Casualties
1977
[Randomized clinical trials in hepatology].
1979
Acute Non-A, Non-B Hepatitis-Clinical, Epidemiological and Histological Characteristics
1980
Causes and characteristics of 500 consecutive cases of jaundice.
1981
The Epidemiology of the Gastrointestinal Randomized Clinical Trial
1977
Prognostic Factors in Cirrhosis Identified by Cox's Regression Model
1983
FATTY LIVER PERSISTING FOR UP TO 33 YEARS
1973
Prognostic Value of Child-Turcotte Criteria in Medically Treated Cirrhosis
1984
Changes of Laboratory Variables With Time in Cirrhosis: Prognostic and Therapeutic Significance
1985
INCIDENCE AND MEANING OF THE " e " DETERMINANT AMONG HEPATITIS-B-ANTIGEN POSITIVE PATIENTS WITH ACUTE AND CHRONIC LIVER DISEASES
1974
Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long‐term follow‐up study
1987
Transvenous liver biopsy in patients with bleeding tendency.
1979
Effect of jejunoileostomy on glucose and insulin metabolism in ten obese patients
1970
Circulating Autoantibodies in Patients with Acute Viral Hepatitis
1980
The Randomized Clinical Trial and Therapeutic Decisions.
1983